Analyst Ratings for Nivalis Therapeutics (NVLS)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 2 / 10
Percentile Rank: 15%
Rating Score: 2 / 10
Percentile Rank: 15%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/29/2016 | Raymond James | N/A | Downgrade | Market Perform (Outperform) |
N/A (N/A) |
6.25 (2.40) |
-61.6% | Details |
| 11/29/2016 | TD Cowen | N/A | Downgrade | (Buy) |
N/A (N/A) |
6.25 (2.40) |
-61.6% | Details |
 |
||||||||
|
||||||||
|
||||||||
